A comparison of qualitative and quantitative fecal immunochemical tests in the Korean national colorectal cancer screening program

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 4, 2012, Pages 461-466

  Park, Mi Jin ^a   Choi, Kui Son ^a   Lee, You Kyoung ^b   Jun, Jae Kwan ^a   Lee, Hoo Yeon ^c  

^a National Cancer Center   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

^c Dankook University   (South Korea)

Author keywords

colorectal cancer screening; fecal immunochemical test; qualitative; quantitative

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; DEMOGRAPHY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HOSPITAL; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAID; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SEX DIFFERENCE;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; REPUBLIC OF KOREA; SENSITIVITY AND SPECIFICITY;

EID: 84863358275     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.668930     Document Type: Article

References (26)

1. Jung K-W, Park S, Kong H-J, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010;25:1113.
2. Bazensky I, Shoobridge-Moran C, Yoder LH. Colorectal cancer: an overview of the epidemiology, risk factors symptoms, and screening guidelines. Medsurg Nurs 2007;16:46.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
4. Sohn DK, Jeong SY, Choi HS, et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat 2005;37:20.
5. Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009;150:162.
6. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7. (Pubitemid 32162983)
7. Ciatto S, Martinelli F, Castiglione G, et al. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the florence screening programme. Br J Cancer 2007;96:218-21. (Pubitemid 46160624)
8. Kui C, Jae J, Hoo-Yeon L, Myung-Il H, Jae O, Eun-Cheol P. Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public Health 2010;10:265.
9. Guittet L, Bouvier V, Mariotte N, et al. Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location. Br J Cancer 2009;100:1230-5.
10. van Dam L, Kuipers EJ, van Leerdam ME. Performance improvements of stool-based screening tests. Best Pract Res Clin Gastroenterol 2010;24:479-92.
11. Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol 2009;105:682-90.
12. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. JNCI J Nat Cancer Inst 2007;99:1462-70.
13. Steele R. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004;329:133.
14. Lim JU, Bae NY, Song WK, Cha JM, Lee JI. The significance of fecal immunochemical test to screen for colorectal cancer in national cancer screening program. Intest Res 2010;8:126-34.
15. Kwon JH, Choi MG, Suh JP, et al. The significance of fecal occult blood testing to screen for colon cancer. Korean J Gastrointest Endosc 2007;35:68-73.
16. Wong WM, Lam SK, Cheung KL, et al. Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer 2003;97:2420-4. (Pubitemid 36542480)
17. Woo HY, Mok RS, Park YN, et al. A prospective study of a new immunochemical fecal occult blood test in Korean patients referred for colonoscopy. Clin Biochem 2005;38:395-9. (Pubitemid 40342871)
18. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90. (Pubitemid 351899018)
19. Tannous B, Leelewandrowski E, Sharples C, et al. Comparison of conventional guaiac to four immunochemical methods for fecal occult blood testing: Implications for clinical practice in hospital and outpatient settings. Clin Chim Acta 2009;400:120-2.
20. Brenner H, Haug U, Hundt S. Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests. Int J Cancer 2010;127:1643-9.
21. Greenberg PD, Bertario L, Gnauck R, et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 2000;95:1331-8. (Pubitemid 30263533)
22. Lee HY, Park EC, Jun JK, Choi KS, Hahm MI. Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea. World J gastroenterol 2010;16:245.
23. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the American college of radiology. Gastroenterology 2008;134:1570-95. (Pubitemid 351615355)
24. Winawer SJ. Colorectal cancer screening. Best Pract Res Clin Gastroenterol 2007;21:1031-48. (Pubitemid 350215368)
25. Ovretveit J, Gustafson D. Evaluation of quality improvement programmes. Qual Saf Health Care 2002;11:270.
26. West E. Management matters: the link between hospital organisation and quality of patient care. Qual Health Care 2001;10:40.